🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/08/2018 | 149,17 | 154,32 | 149,17 | 151,21 | +0,87% | 3,45% | 535.883 |
| 09/08/2018 | 148,66 | 153,78 | 146,84 | 149,91 | +0,84% | 4,67% | 603.850 |
| 08/08/2018 | 153,77 | 154,79 | 146,99 | 148,66 | -3,53% | 5,07% | 782.104 |
| 07/08/2018 | 146,60 | 158,60 | 146,60 | 154,10 | +8,94% | 8,19% | 1.665.196 |
| 06/08/2018 | 141,61 | 143,47 | 138,65 | 141,45 | +0,76% | 3,40% | 513.441 |
| 03/08/2018 | 140,67 | 141,19 | 138,50 | 140,39 | +0,37% | 1,91% | 431.688 |
| 02/08/2018 | 137,37 | 140,30 | 137,37 | 139,86 | +1,04% | 2,13% | 340.798 |
| 01/08/2018 | 135,82 | 138,55 | 135,73 | 138,42 | +1,63% | 2,08% | 423.032 |
| 31/07/2018 | 134,80 | 137,92 | 132,93 | 136,20 | +1,37% | 3,70% | 579.485 |
| 30/07/2018 | 139,81 | 140,62 | 133,44 | 134,35 | -3,46% | 5,14% | 699.389 |
| 27/07/2018 | 145,66 | 145,83 | 136,00 | 139,16 | -4,07% | 6,75% | 506.388 |
| 26/07/2018 | 142,44 | 146,13 | 142,44 | 145,07 | +0,91% | 2,59% | 288.380 |
| 25/07/2018 | 143,49 | 144,03 | 142,57 | 143,77 | +0,51% | 1,02% | 333.264 |
| 24/07/2018 | 144,66 | 145,50 | 141,88 | 143,04 | -0,34% | 2,50% | 297.998 |
| 23/07/2018 | 144,73 | 145,11 | 141,76 | 143,53 | -0,78% | 2,31% | 354.584 |
| 20/07/2018 | 145,07 | 146,55 | 144,42 | 144,65 | -0,28% | 1,47% | 364.522 |
| 19/07/2018 | 140,99 | 146,63 | 140,99 | 145,07 | +2,56% | 4,00% | 636.872 |
| 18/07/2018 | 138,46 | 143,46 | 137,92 | 141,44 | +2,25% | 4,00% | 536.364 |
| 17/07/2018 | 136,62 | 138,98 | 136,62 | 138,33 | +0,88% | 1,73% | 354.103 |
| 16/07/2018 | 138,18 | 138,52 | 135,81 | 137,13 | -0,57% | 1,96% | 322.203 |
| 13/07/2018 | 137,86 | 139,73 | 137,60 | 137,92 | +0,16% | 1,54% | 286.937 |
| 12/07/2018 | 137,14 | 141,20 | 136,00 | 137,70 | +2,26% | 3,80% | 710.450 |
| 11/07/2018 | 132,65 | 135,31 | 132,09 | 134,65 | +0,88% | 2,43% | 268.663 |
| 10/07/2018 | 135,05 | 135,51 | 131,94 | 133,47 | -0,50% | 2,65% | 290.143 |
| 09/07/2018 | 136,19 | 136,79 | 132,75 | 134,15 | -0,75% | 2,96% | 327.653 |
| 06/07/2018 | 132,84 | 137,09 | 132,59 | 135,17 | +2,28% | 3,39% | 563.775 |
| 05/07/2018 | 133,47 | 133,83 | 131,01 | 132,15 | -0,24% | 2,11% | 351.538 |
| 03/07/2018 | 132,99 | 134,88 | 131,27 | 132,46 | +0,54% | 2,72% | 248.465 |
| 02/07/2018 | 129,06 | 131,94 | 127,91 | 131,74 | +1,94% | 3,12% | 361.477 |
| 29/06/2018 | 130,38 | 131,09 | 127,49 | 129,24 | -0,39% | 2,76% | 744.433 |